1. Treating CNS sarcoidosis with infliximab and mycophenolate mofetil

   • James Corbett

   Clinical Trials Report 01 August 2009 Pages: 339 - 340

2. Alemtuzumab versus interferon beta-1a in early multiple sclerosis

   • Dennis Bourdette
   • Vijayshree Yadav

   Clinical Trials Report 01 August 2009 Pages: 341 - 342

3. Update on amyloid imaging: From healthy aging to Alzheimer’s disease

   • David A. Wolk
   • William E. Klunk

   OriginalPaper 01 August 2009 Pages: 345 - 352

4. TDP-43 and frontotemporal dementia

   • William T. Hu
   • Murray Grossman

   OriginalPaper 01 August 2009 Pages: 353 - 358

5. Immunologically mediated dementias

   • Michael H. Rosenbloom
   • Sallie Smith
   • Michael D. Geschwind

   OriginalPaper 01 August 2009 Pages: 359 - 367

6. An update on treatment and prevention strategies for Alzheimer’s disease

   • Judith Neugroschl
   • Mary Sano

   OriginalPaper 01 August 2009 Pages: 368 - 376

7. Neuro-ophthalmology and the anti-GQ1b antibody syndromes

   • Robert F. Saul

   OriginalPaper 01 August 2009 Pages: 379 - 383

8. Current pharmacologic testing for horner syndrome

   • Mansoor Mughal
   • Reid Longmuir

   OriginalPaper 01 August 2009 Pages: 384 - 389

9. Selected lid problems in neurologic practice

   • Gregory S. Kosmorsky
   • Alyssa Fiddler

   OriginalPaper 01 August 2009 Pages: 390 - 395

10. Gray matter pathology and multiple sclerosis

    • Christiane Wegner
    • Christine Stadelmann

    OriginalPaper 01 August 2009 Pages: 399 - 404

11. Epstein-barr virus in multiple sclerosis

    • Bridget A. Bagert

    OriginalPaper 01 August 2009 Pages: 405 - 410

12. Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis

    • Kimmy G. Su
    • Gary Banker
    • Michael Forte

    OriginalPaper 01 August 2009 Pages: 411 - 417